Ling-Yu Kuan

423 total citations
5 papers, 333 citations indexed

About

Ling-Yu Kuan is a scholar working on Immunology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Ling-Yu Kuan has authored 5 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Oncology. Recurrent topics in Ling-Yu Kuan's work include Immunotherapy and Immune Responses (5 papers), Prostate Cancer Treatment and Research (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Ling-Yu Kuan is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Prostate Cancer Treatment and Research (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Ling-Yu Kuan collaborates with scholars based in United States. Ling-Yu Kuan's co-authors include Corazon dela Rosa, Nadeem A. Sheikh, Mark W. Frohlich, David L. Urdal, Philip W. Kantoff, Daniel P. Petrylak, Christian Poehlein, James Trager, James B. Whitmore and Vivian Goodell and has published in prestigious journals such as Cancer Research, Journal of Immunological Methods and Cancer Immunology Immunotherapy.

In The Last Decade

Ling-Yu Kuan

5 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ling-Yu Kuan United States 4 251 192 101 70 30 5 333
Christophe Lonchay Belgium 8 237 0.9× 157 0.8× 76 0.8× 146 2.1× 19 0.6× 12 387
Katrin Deiser Germany 10 336 1.3× 240 1.3× 20 0.2× 85 1.2× 40 1.3× 14 470
Richard Wnek United States 10 141 0.6× 143 0.7× 24 0.2× 89 1.3× 22 0.7× 14 284
Ulf Forssmann Germany 11 207 0.8× 152 0.8× 56 0.6× 189 2.7× 104 3.5× 24 409
Avantika S. Chitre United States 6 253 1.0× 222 1.2× 34 0.3× 68 1.0× 8 0.3× 8 387
Anusha Muralidhar United States 6 152 0.6× 98 0.5× 29 0.3× 68 1.0× 20 0.7× 7 264
Matthew Adamow United States 7 398 1.6× 350 1.8× 31 0.3× 127 1.8× 25 0.8× 12 525
Lisa Skarupa United States 6 482 1.9× 399 2.1× 193 1.9× 148 2.1× 28 0.9× 6 577
Olga Maksimovic Germany 7 146 0.6× 98 0.5× 37 0.4× 180 2.6× 36 1.2× 13 316
Branka Petričević Austria 7 166 0.7× 147 0.8× 40 0.4× 76 1.1× 88 2.9× 13 298

Countries citing papers authored by Ling-Yu Kuan

Since Specialization
Citations

This map shows the geographic impact of Ling-Yu Kuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling-Yu Kuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling-Yu Kuan more than expected).

Fields of papers citing papers by Ling-Yu Kuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling-Yu Kuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling-Yu Kuan. The network helps show where Ling-Yu Kuan may publish in the future.

Co-authorship network of co-authors of Ling-Yu Kuan

This figure shows the co-authorship network connecting the top 25 collaborators of Ling-Yu Kuan. A scholar is included among the top collaborators of Ling-Yu Kuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling-Yu Kuan. Ling-Yu Kuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Sheikh, Nadeem A., Daniel P. Petrylak, Philip W. Kantoff, et al.. (2012). Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer. Cancer Immunology Immunotherapy. 62(1). 137–147. 203 indexed citations
2.
Wesley, Johnna D., Ling-Yu Kuan, Eric Chadwick, et al.. (2011). Abstract 5509: Evidence of T lymphocyte activation following sipuleucel-T treatment. Cancer Research. 71(8_Supplement). 5509–5509. 3 indexed citations
3.
Sheikh, Nadeem A., et al.. (2010). Abstract 2932: Sipuleucel-T generates robust and persistent cellular and humoral immune responses - Results from the IMPACT trial. Cancer Research. 70(8_Supplement). 2932–2932. 3 indexed citations
4.
Disis, Mary L., Corazon dela Rosa, Vivian Goodell, et al.. (2005). Maximizing the retention of antigen specific lymphocyte function after cryopreservation. Journal of Immunological Methods. 308(1-2). 13–18. 122 indexed citations
5.
Disis, ML, Vivian Goodell, Ling-Yu Kuan, et al.. (2004). Maximizing the Retention of Antigen Specific Lymphocyte Function after Cryopreservation. Journal of Immunotherapy. 27(6). S40–S40. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026